Trading Signals: FOLD Stock Price Prediction and Forecast (Thu. May. 31, 2007 - Fri. Dec. 22, 2023)(Amicus Therapeutics Inc)
| FOLD latest price $11.1950 (1.36%) ($11.1950 - $11.1950) on Thu. Mar. 23, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.43% (three month average) | RSI | 25 | Latest Price | $11.1950(1.36%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | FOLD declines -0.7% a day on average for past five trading days. | Weekly Trend | FOLD declines -3.4% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support FOLD advance at 0% a week (0% probability) XBI(60%) IBB(57%) IWO(44%) IWM(43%) IWC(41%) | Factors Impacting FOLD price | FOLD will decline at least -1.215% in a week (0% probabilities). VXX(-19%) TBT(-19%) UUP(-11%) VIXM(-8%) BNDX(-6%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.215% (StdDev 2.43%) | Hourly BBV | -1.2 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-1.23(-110.99%) | Resistance Level | $11.95 | 5 Day Moving Average | $11.28(-0.75%) | 10 Day Moving Average | $11.35(-1.37%) | 20 Day Moving Average | $11.95(-6.32%) | To recent high | -18% | To recent low | 1.4% | Market Cap | $2.891b | | | | Amicus Therapeutics, Inc. is a biotechnology company focused on discovering, developing, and delivering medicines for people living with rare metabolic diseases. The company is committed to advancing and expanding a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. Amicus Therapeutics has a portfolio of product opportunities including the first and only approved oral precision medicine for people living with Fabry disease who have amenable genetic variants; a novel, clinical-stage, treatment paradigm for Pompe disease; and a rare disease gene therapy portfolio. The company was founded on February 4, 2002 and is headquartered in Cranbury, NJ. |